The √ ǫ-expansions for critical exponents of the weakly-disordered Ising model are calculated up to the five-loop order and found to possess coefficients with irregular signs and values. The estimate n c = 2.855 for the marginal spin dimensionality of the cubic model is obtained by the Pade-Borel resummation of corresponding five-loop ǫ-expansion.
The critical behavior of two-dimensional (2D) anisotropic systems with weak quenched disorder described by the so-called generalized Ashkin-Teller model (GATM) is studied. In the critical region this model is shown to be described by a multifermion field theory similar to the Gross-Neveu model with a few independent quartic coupling constants. Renormalization group calculations are used to obtain the temperature dependence near the critical point of some thermodynamic quantities and the large distance behavior of the two-spin correlation function. The equation of state at criticality is also obtained in this framework. We find that random models described by the GATM belong to the same universality class as that of the two-dimensional Ising model. The critical exponent ν of the correlation length for the 3-and 4-state randombond Potts models is also calculated in a 3-loop approximation. We show that this exponent is given by an apparently convergent series in ǫ = c − 1 2 (with c the central charge of the Potts model) and that the numerical values of ν are very close to that of the 2D Ising model. This work therefore supports the conjecture (valid only approximately for the 3-and 4-state Potts models) of a superuniversality for the 2D disordered models with discrete symmetries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.